The endothelial nitric oxide synthase (Glu298Asp and-786T>C) gene polymorphisms are associated with coronary in-stent restenosis

被引:64
作者
Gomma, AH
Elrayess, MA
Knight, CJ
Hawe, E
Fox, KM
Humphries, SE
机构
[1] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, London SW3 6NP, England
[2] Natl Heart & Lung Inst, London, England
[3] London Chest Hosp, London E2 9JX, England
[4] Royal Free & & UCL Med Sch, Labs Cardiovasc Genet Studies, British Heart Fdn, London, England
关键词
eNOS polymorphism; restenosis; stents; genes; angiography;
D O I
10.1053/euhj.2002.3400
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Coronary stent deployment is a major advance in percutaneous treatment of ischaemic heart disease, but 10-40% of patients still develop angiographic restenosis by 6 months due to neointimal hyperplasia. Patient-specific factors, including genetic factors, can contribute to this process. We have conducted a prospective study to examine the involvement of genetic risk factors (eNOS, ACE, MMP-3, IL-6, and PECAM-1) in restenosis following coronary stent deployment. showed a higher frequency of restenosis with an odds ratio of 1(.)88 (95%CI: 1(.)01-3(.)51, P=0(.)043) compared to 298Glu homozygotes. Carriers of the -786C allele of the eNOS -786T>C polymorphism also showed a higher frequency of restenosis with odds ratio of 2(.)06 (95%CI: 1(.)08-3(.)94, P=0(.)028). These effects were essentially additive and were independent of other classical risk factors. Other studied genes did not show significant association with coronary in-stent restenosis. Methods and Results A total of 226 patients who underwent elective and successful coronary artery stenting to de novo lesions in native coronary arteries were studied. Two hundred and five (90(.)7%) patients were restudied by coronary angiogram at 6 months and the stented lesions were assessed using an automated quantitative angiography system. Genotype was determined by polymerase chain reaction (PCR) and restriction enzyme digestion. Restenosis rate, defined as greater than or equal to50% diameter stenosis, was 29(.)3%. The overall genotype frequency distributions were in Hardy-Weinberg equilibrium for all variants. Carriers of the 298Asp allele of the eNOS Glu298Asp polymorphism Conclusion In patients with coronary artery disease, the possession of the 298Asp and -786C variants of the eNOS gene are a risk factor for coronary in-stent restenosis, demonstrating the importance of the nitric oxide system in restenosis. (C) 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1955 / 1962
页数:8
相关论文
共 35 条
  • [1] A COMPARISON OF DIRECTIONAL ATHERECTOMY WITH BALLOON ANGIOPLASTY FOR LESIONS OF THE LEFT ANTERIOR DESCENDING CORONARY-ARTERY
    ADELMAN, AG
    COHEN, EA
    KIMBALL, BP
    BONAN, R
    RICCI, DR
    WEBB, JG
    LARAMEE, L
    BARBEAU, G
    TRABOULSI, M
    CORBETT, BN
    SCHWARTZ, L
    LOGAN, AG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (04) : 228 - 233
  • [2] Amant C, 1997, CIRCULATION, V96, P56
  • [3] BOLLA MK, 1995, CLIN CHEM, V41, P1599
  • [4] RELEASE OF ENDOTHELIN FROM THE PORCINE AORTA - INHIBITION BY ENDOTHELIUM-DERIVED NITRIC-OXIDE
    BOULANGER, C
    LUSCHER, TF
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (02) : 587 - 590
  • [5] Interleukin-6 gene -174G > C and -572G > C promoter polymorphisms are strong predictors of plasma -: Interleukin-6 levels after coronary artery bypass surgery
    Brull, DJ
    Montgomery, HE
    Sanders, J
    Dhamrait, S
    Luong, L
    Rumley, A
    Lowe, GDO
    Humphries, SE
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (09) : 1458 - 1463
  • [6] Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis
    de Maat, MPM
    Jukema, JW
    Ye, S
    Zwinderman, AH
    Moghaddam, PH
    Beekman, M
    Kastelein, JJP
    van Boven, AJ
    Bruschke, AVG
    Humphries, SE
    Kluft, C
    Henney, AM
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (06) : 852 - 856
  • [7] CORONARY MORPHOLOGICAL AND CLINICAL DETERMINANTS OF PROCEDURAL OUTCOME WITH ANGIOPLASTY FOR MULTIVESSEL CORONARY-DISEASE - IMPLICATIONS FOR PATIENT SELECTION
    ELLIS, SG
    VANDORMAEL, MG
    COWLEY, MJ
    DISCIASCIO, G
    DELIGONUL, U
    TOPOL, EJ
    BULLE, TM
    [J]. CIRCULATION, 1990, 82 (04) : 1193 - 1202
  • [8] A RANDOMIZED COMPARISON OF CORONARY-STENT PLACEMENT AND BALLOON ANGIOPLASTY IN THE TREATMENT OF CORONARY-ARTERY DISEASE
    FISCHMAN, DL
    LEON, MB
    BAIM, DS
    SCHATZ, RA
    SAVAGE, MP
    PENN, I
    DETRE, K
    VELTRI, L
    RICCI, D
    NOBUYOSHI, M
    CLEMAN, M
    HEUSER, R
    ALMOND, D
    TEIRSTEIN, PS
    FISH, RD
    COLOMBO, A
    BRINKER, J
    MOSES, J
    SHAKNOVICH, A
    HIRSHFELD, J
    BAILEY, S
    ELLIS, S
    RAKE, R
    GOLDBERG, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (08) : 496 - 501
  • [9] The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis
    Fishman, D
    Faulds, G
    Jeffery, R
    Mohamed-Ali, V
    Yudkin, JS
    Humphries, S
    Woo, P
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) : 1369 - 1376
  • [10] NITRIC OXIDE-GENERATING VASODILATORS AND 8-BROMO-CYCLIC GUANOSINE-MONOPHOSPHATE INHIBIT MITOGENESIS AND PROLIFERATION OF CULTURED RAT VASCULAR SMOOTH-MUSCLE CELLS
    GARG, UC
    HASSID, A
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (05) : 1774 - 1777